October 30, 2014

Matrixx Initiatives on Thursday launched a new cold-shortening nasal spray with symptom relief under its popular Zicam Cold Remedy Brand. 

October 30, 2014

Sandoz, through its branded dermatology business PharmaDerm, and Medigene AG on Thursday announced a promotion agreement with Women's Choice Pharmaceuticals for Veregen (sinecatechins) ointment, 15% strength. 

October 29, 2014

Consumers want to know: do disinfectant products like Reckitt Benckiser's Lysol or Clorox protect against the Ebola virus?

October 28, 2014

he Food and Drug Administration last week announced approval for Obizur for the treatment of bleeding episodes in adults with acquired hemophilia A. 

October 28, 2014

The Retail Orphan Initiative on Tuesday hosted a webinar detailing a major charitable campaign to fight Ebola in Liberia.

October 27, 2014

Responding to the Ebola virus epidemic, the Retail Orphan Initiative on Monday announced a major campaign to help fight Ebola in Liberia. 

October 27, 2014

Rx Response moved to alert status in response to the concern about Ebola in the United States.

October 24, 2014

GM Pharmaceuticals on Wednesday announced the launch of TexaClear, a new liquid allergy, sinus, cough-cold and flu line, made by Texans for Texans.

October 23, 2014

GlaxoSmithKline expects to have its Ebola vaccine available by year's end.

October 22, 2014

The pharmaceutical industry has committed considerable resources to developing both vaccines and treatments to address the current Ebola crisis.

 

October 17, 2014

A new study published Thursday by the Center for Healthcare Supply Chain Research identifies factors, based on an analysis of European models, that may affect the American launch of biosimilars and their marketplace potential in the United States.

October 17, 2014

Pillar Rock USA recently introduced JetRyte, a nutritional supplement formulated to combat jet lag. 

October 15, 2014

Procter & Gamble earlier this year added some heft to its Metamucil brand with a pair of line extensions that create a linear brand block.

October 14, 2014

Cardinal Health on Tuesday announced it had recently donated more than 1 million products to AmeriCares Emergency Response Program to help contain the deadly Ebola outbreak in West Africa. 

October 10, 2014

The Food and Drug Administration on Friday approved Gilead's Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus genotype 1 infection.

October 10, 2014

The National Association of Chain Drug Stores submitted a written statement in lead-up to a forum hosted by U.S. Rep. Renee Ellmers, R-N.C.

October 9, 2014

At a time when nearly every media outlet is covering Ebola, Enterovirus D-68, or a new outbreak of an infectious disease, the American Pharmacists Association is reminding Americans that the nation’s pharmacists are ready to help.

October 9, 2014

National leaders in hypertension have acknowledged PharmaSmart as the only blood pressure kiosk solution that can be “recommended by physicians” for patient monitoring, the company announced Thursday.

October 8, 2014

The dietary supplement industry on Tuesday spoke out against any supplement manufacturer making advertising claims around the Ebola virus.

October 7, 2014

Biopharmaceutical company Chimerix on Monday announced that brincidofovir has been provided for potential use in patients with Ebola virus at the request of treating physicians.

October 7, 2014

GoJo on Monday announced today that it will support City of Hope, a research and treatment center for cancer, diabetes and life-threatening diseases located in Los Angeles, through a special promotion.

October 7, 2014

America’s biopharmaceutical research companies are currently developing nearly 800 new medicines and vaccines for cancer, according to a new PhRMA report.

 

October 6, 2014

Seven influenza vaccine manufacturers projected that as many as 151 million to 159 million doses of influenza vaccine will be available for use in the United States.

October 6, 2014

FloraTummys is a new probiotic especially made for kids rather than a line extension of the adult probiotic.